Scan to Download
One power score. Smarter investment decisions
Conduit Pharmaceuticals Inc
CDT0.721USD
+0.035+5.07%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
1.73MMarket Cap
LossP/E TTM
Conduit Pharmaceuticals Inc
0.721
+0.035+5.07%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating expenses
57.71%4.95M
35.67%4.01M
292.51%3.51M
443.59%5.81M
82.88%3.14M
47.16%2.96M
-46.54%895.00K
14.58%1.07M
555.34%1.72M
590.03%2.01M
--1.67M
--933.00K
--262.00K
--291.00K
R&D expenses
7340.00%1.86M
922.66%1.31M
46.67%132.00K
--3.09M
--25.00K
--128.00K
--90.00K
-100.00%0.00
----
----
----
--38.00K
----
----
Depreciation, depletion, and amortization
--835.00K
--190.00K
--452.00K
--5.00K
----
----
----
----
----
----
----
----
----
----
Other operating expenses
----
----
----
----
----
----
----
----
----
----
---47.00K
--120.00K
----
----
Operating profit
-57.71%-4.95M
-35.67%-4.01M
-292.51%-3.51M
-443.59%-5.81M
-82.88%-3.14M
-47.16%-2.96M
46.54%-895.00K
-14.58%-1.07M
-555.34%-1.72M
-590.03%-2.01M
---1.67M
---933.00K
---262.00K
---291.00K
Net non-operating interest income (expenses)
Non-operating interest income
100.00%4.00K
-11.11%8.00K
-86.67%2.00K
----
--2.00K
--9.00K
--15.00K
----
----
----
----
----
----
----
Non-operating interest expense
-52.10%57.00K
47.90%176.00K
705.88%959.00K
557.45%309.00K
205.13%119.00K
2280.00%119.00K
--119.00K
--47.00K
--39.00K
--5.00K
----
----
----
----
Special income (expenses)
----
--100.00K
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
51.88%-1.02M
-119.51%-1.07M
-25.70%2.06M
-110.99%-341.00K
-182.71%-2.13M
-220.39%-487.00K
298.85%2.78M
13586.96%3.10M
-158.42%-752.00K
-850.00%-152.00K
---1.40M
---23.00K
---291.00K
---16.00K
Income before tax
-11.98%-6.03M
-44.88%-5.15M
-235.24%-2.41M
-425.33%-6.46M
-114.63%-5.38M
-64.06%-3.55M
157.93%1.78M
307.74%1.99M
-353.53%-2.51M
-605.21%-2.17M
---3.07M
---956.00K
---553.00K
---307.00K
Income after tax
-11.98%-6.03M
-44.88%-5.15M
-235.24%-2.41M
-425.33%-6.46M
-114.63%-5.38M
-64.06%-3.55M
157.93%1.78M
307.74%1.99M
-353.53%-2.51M
-605.21%-2.17M
---3.07M
---956.00K
---553.00K
---307.00K
Net income from continuous operations
-11.98%-6.03M
-44.88%-5.15M
-235.24%-2.41M
-425.33%-6.46M
-114.63%-5.38M
-64.06%-3.55M
157.93%1.78M
307.74%1.99M
-353.53%-2.51M
-605.21%-2.17M
---3.07M
---956.00K
---553.00K
---307.00K
Net income attributable to controlling interests
-11.98%-6.03M
-44.88%-5.15M
-235.24%-2.41M
-425.33%-6.46M
-114.63%-5.38M
-64.06%-3.55M
157.93%1.78M
307.74%1.99M
-353.53%-2.51M
-605.21%-2.17M
---3.07M
---956.00K
---553.00K
---307.00K
Net income attributable to common shareholders
-11.98%-6.03M
-44.88%-5.15M
-235.24%-2.41M
-425.33%-6.46M
-114.63%-5.38M
-64.06%-3.55M
157.93%1.78M
307.74%1.99M
-353.53%-2.51M
-605.21%-2.17M
---3.07M
---956.00K
---553.00K
---307.00K
Basic earnings per share
95.00%-5.46
72.47%-19.86
-188.48%-32.25
-344.17%-111.19
-94.63%-109.33
-48.81%-72.17
153.00%36.45
312.75%45.54
-353.39%-56.17
-605.90%-48.49
---68.78
---21.41
---12.39
---6.87
Diluted earnings per share
95.00%-5.46
72.47%-19.86
-188.48%-32.25
-346.85%-111.19
-94.63%-109.33
-48.81%-72.17
153.00%36.45
310.44%45.05
-353.39%-56.17
-605.90%-48.49
---68.78
---21.41
---12.39
---6.87
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
